DCGI Seek Serum Institute Of India Clarification On Oxford COVID-19 Vaccine Trials

Like
Like Love Haha Wow Sad Angry

Serum Institute of India (SII) has been asked to revise its protocol for the COVID-19 vaccine trial by a CDSCO panel after they submitted an application to Drugs Controller General of India (DCGI) requesting permission for conducting phase 2 and 3 human clinical trials of the candidate COVID-19 vaccine by Oxford University. A meeting of […]

The post DCGI Seek Serum Institute Of India Clarification On Oxford COVID-19 Vaccine Trials appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/07/oxford-vaccine-trial-in-india-dcgi-seek-sii-further-clarification/

Like
Like Love Haha Wow Sad Angry